Design Therapeutics, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $0.0 | $0.0 | — | — | — |
| Operating income | -$79.5 | -$62.4 | -$78.2 | -$67.6 | -$35.8 |
| Net income | -$69.8 | -$49.6 | -$66.9 | -$63.3 | -$35.5 |
| Cash Flow Statement | |||||
| Free cash flow | -$54.6 | -$43.4 | -$58.8 | -$52.2 | -$30.9 |
Shares outstanding 62.6M · Free float 49.1%
Annual filing data through FY ended December 31, 2025; float as of September 13, 2026.